- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04711733
Supportive Care Needs of Former Child, AYA Cancer Patients, and of Their Parents: Evaluation During Long-term Follow-up (ExPEDAJAC)
Supportive Care Needs of Former Child, Adolescent and Young Adult Cancer Patients, and of Their Parents: Evaluation During Long-term Follow-up
Each year, there are 2100 new cases of cancer in children and adolescents/young adults (AYA) in France. Due to a significant improvement in the effectiveness of therapies, the survival rate of all types of cancer combined after 5 years is 80-85%. This is leading to the emergence of new problems, which require an adaptation of the long-term care of these former patients. Nevertheless, although some medical complications have been widely described and are the subject of recommendations, many questions remain unanswered regarding the real long-term needs of patients and of their main caregivers.
The main objective of this study is to assess not only the specific supportive care needs of former onco-hematology patients treated before the age of 25 years, but also those of their parents up to 6 months after the end of the oncological follow-up, i.e. 3 to 5 years after the diagnosis.
The secondary objectives aim to:
- Assess adherence to long-term follow-up medical consultation
- Assess the early complications presented by the patients
- Assess the quality of life and the anxiety-depression of former patients and their parents
- Describe and evaluate the offer and use of the network of health professionals aware of the post-treatment issues; assess the referral to the network of health professionals aware of the post-treatment issues.
Depending on the objectives, the methodology used in this study is mixed, qualitative and quantitative. The study will be proposed systematically to all former patients of the hospital department diagnosed before the age of 25 years and at least 6 years of age at the time of inclusion as well as to their parents. A sample of 60 former pediatric patients (20 per age group) and 60-120 parents (ideally 40 per age group) is expected.
At the scientific level, this study will provide a better understanding of the cognitive and emotional processes involved in the long-term follow-up, in particular by identifying the supportive care needs of different participants (former patients and parents) and their experiences and quality of life during the long-term follow-up phase. At the individual level, this pilot study will enable the development of a multiprofessional structure, expert in cancer after-care from the end of the oncological follow-up.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Rational Each year, there are 2100 new cases of cancer in children and adolescents/young adults (AYA) in France. Due to a significant improvement in the effectiveness of therapies, the survival rate of all types of cancer combined after 5 years is 80-85%. This is leading to the emergence of new problems, which require an adaptation of the long-term care of these former patients. Many studies highlight that 60 to 65% of pediatric oncology patients will present medical and/or psychosocial complications in the 20 years following their oncological treatment, with a cumulative incidence of a serious adverse event of 40% 30 years after the cancer diagnosis. Nevertheless, although some medical complications have been widely described and are the subject of recommendations, many questions remain unanswered regarding the real long-term needs of patients and of their main caregivers, in this project their parents. It is therefore necessary to identify the risk factors by determining the expectations and the supportive care needs of patients and their caregivers in the long-term follow-up in order to intervene early and thus reduce the incidence of these later complications.
However, only 30 to 50% of former patients in pediatric oncology-hematology and their family attend a long-term follow-up medical consultation. We hypothesize that this lack of commitment is multifactorial (e.g. unmet supportive care needs, geographical distance from home, lack of information about the importance of long-term follow-up and follow-up structures nearby) and that a precise study of the needs expressed by former patients and their family should lead to an improved attendance at these consultations.
A better understanding of the supportive care needs of these patients and their families, as well as the brakes/obstacles or lers of their compliance with a long-term follow-up, is therefore essential to improve their quality of life, prevent or detect the sequela of therapies and reduce the risk of morbidity/mortality.
Objectives The main objective of this study is to assess not only the specific supportive care needs of former onco-hematology patients treated before the age of 25 years, but also those of their parents up to 6 months after the end of the oncological follow-up, i.e. 3 to 5 years after the diagnosis.
The secondary objectives aim to:
- Assess adherence to long-term follow-up medical consultation
- Assess the early complications presented by the patients
- Assess the quality of life and the anxiety-depression of former patients and their parents
- Describe and evaluate the offer and use of the network of health professionals aware of the post-treatment issues; assess the referral to the network of health professionals aware of the post-treatment issues.
Methodology Depending on the objectives, the methodology used in this study is mixed, qualitative and quantitative. The study will be proposed systematically to all former patients of the hospital department diagnosed before the age of 25 years and at least 6 years of age at the time of inclusion as well as to their parents. The experiences and the specific needs of each person (patients, mothers and fathers) will be assessed independently. Three independent groups will be formed based on the age of the patient when included in the study. For each group, the parents may or may not be paired with the patients. A sample of 60 former pediatric patients (20 per age group) and 60-120 parents (ideally 40 per age group) is expected.
Expected results At the scientific level, this study will provide a better understanding of the cognitive and emotional processes involved in the long-term follow-up, in particular by identifying the supportive care needs of different participants (former patients and parents) and their experiences and quality of life during the long-term follow-up phase. This first stage will be followed by more powerful studies on the modalities of following-up patients after cancer, in order to add to previously published research on the long-term medical and psychological side effects.
At the individual level, this pilot study will enable the development of a multiprofessional structure, expert in cancer after-care from the end of the oncological follow-up. This support could be initiated early and the link with the local network established quickly. It should reduce the experience of being abandoned presented by former patients and their families. At the family level, studying the needs expressed by parents could lead to a family psychological approach in order to restore the family links impacted by the disease.
At the organizational level, this study should serve as a basis for developing a structure that can carry out tertiary prevention, and thus reduce the costs attributable to long-term side effects (e.g. educational and professional absenteeism, use of treatments, private consultations or even hospitalization).
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
LYON Cedex 08, France, 69373
- Centre Léon Bérard - Institut d'Hémato-Oncologie Pediatrique
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age of the patient or the parent of a patient aged ≤ 25 years at diagnosis and at least 6 years of age at the time of inclusion
- Patient, or the parent of a patient, previously treated at Institut d'Hématologie et d'Oncologie Pédiatrique /Leon Berard comprehensive cancer centre
- Patient treated for a solid tumor or a lymphoma
- Patient in complete response and having finished his/her standard oncological monitoring between 1 and 6 months ago i.e. 3 to 5 years after the diagnosis
- Patients and parents capable of understanding, reading and writing French
- Patient affiliated to a health insurance plan
- Having been informed of the study and not objecting to it
Exclusion Criteria:
- Cannot be followed-up for medical, social, familial, geographical or psychological reasons, throughout the duration of the study
- Deprived of liberty by a court or administrative decision
- Person who refused to participate or was incapable of objecting in an informed manner
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients 6-14 years old
Individual interview + Self-report questionnaire + long-term follow-up medical consultation + At 1 year : Assessment of prescription's adherence
|
The qualitative interview aims to identify the supportive care needs of patients and parents as well as their expectations with regard to a long-term follow-up.
To assess the quality of life, anxiety/depression of former patients and relatives: For child and adolescent patients (less than 15 years old at inclusion):
For patients over 15 years of age at the time of inclusion and parents:
To describe and evaluate the offer and use of the network of health professionals who are aware of post-treatment issues: number of consultations, speciality and location of the professionals requested following the long-term follow-up consultation, time between referral and first consultation, evaluation of the geographical accessibility of care around the patient's home. To assess adherence to long-term follow-up medical consultation: - number of patients summoned/ number of consultations carried out ; reason for refusal of long-term follow-up medical consultation To assess medical complications through clinical data collection |
|
Parents of 6-14 years old patients
Individual interview + Self-report questionnaire
|
The qualitative interview aims to identify the supportive care needs of patients and parents as well as their expectations with regard to a long-term follow-up.
To assess the quality of life, anxiety/depression of former patients and relatives: For child and adolescent patients (less than 15 years old at inclusion):
For patients over 15 years of age at the time of inclusion and parents:
To describe and evaluate the offer and use of the network of health professionals who are aware of post-treatment issues: number of consultations, speciality and location of the professionals requested following the long-term follow-up consultation, time between referral and first consultation, evaluation of the geographical accessibility of care around the patient's home. |
|
Patients 15-25 years old
Individual interview + Self-report questionnaire + long-term follow-up medical consultation + At 1 year : Assessment of prescription's adherence
|
The qualitative interview aims to identify the supportive care needs of patients and parents as well as their expectations with regard to a long-term follow-up.
To assess the quality of life, anxiety/depression of former patients and relatives: For child and adolescent patients (less than 15 years old at inclusion):
For patients over 15 years of age at the time of inclusion and parents:
To describe and evaluate the offer and use of the network of health professionals who are aware of post-treatment issues: number of consultations, speciality and location of the professionals requested following the long-term follow-up consultation, time between referral and first consultation, evaluation of the geographical accessibility of care around the patient's home. To assess adherence to long-term follow-up medical consultation: - number of patients summoned/ number of consultations carried out ; reason for refusal of long-term follow-up medical consultation To assess medical complications through clinical data collection |
|
Parents of 15-25 years old patients
Individual interview + Self-report questionnaire
|
The qualitative interview aims to identify the supportive care needs of patients and parents as well as their expectations with regard to a long-term follow-up.
To assess the quality of life, anxiety/depression of former patients and relatives: For child and adolescent patients (less than 15 years old at inclusion):
For patients over 15 years of age at the time of inclusion and parents:
To describe and evaluate the offer and use of the network of health professionals who are aware of post-treatment issues: number of consultations, speciality and location of the professionals requested following the long-term follow-up consultation, time between referral and first consultation, evaluation of the geographical accessibility of care around the patient's home. |
|
Patients > 25 years old
Individual interview + Self-report questionnaire + long-term follow-up medical consultation + At 1 year : Assessment of prescription's adherence
|
The qualitative interview aims to identify the supportive care needs of patients and parents as well as their expectations with regard to a long-term follow-up.
To assess the quality of life, anxiety/depression of former patients and relatives: For child and adolescent patients (less than 15 years old at inclusion):
For patients over 15 years of age at the time of inclusion and parents:
To describe and evaluate the offer and use of the network of health professionals who are aware of post-treatment issues: number of consultations, speciality and location of the professionals requested following the long-term follow-up consultation, time between referral and first consultation, evaluation of the geographical accessibility of care around the patient's home. To assess adherence to long-term follow-up medical consultation: - number of patients summoned/ number of consultations carried out ; reason for refusal of long-term follow-up medical consultation To assess medical complications through clinical data collection |
|
Parents of > 25 years old patients
Individual interview + Self-report questionnaire
|
The qualitative interview aims to identify the supportive care needs of patients and parents as well as their expectations with regard to a long-term follow-up.
To assess the quality of life, anxiety/depression of former patients and relatives: For child and adolescent patients (less than 15 years old at inclusion):
For patients over 15 years of age at the time of inclusion and parents:
To describe and evaluate the offer and use of the network of health professionals who are aware of post-treatment issues: number of consultations, speciality and location of the professionals requested following the long-term follow-up consultation, time between referral and first consultation, evaluation of the geographical accessibility of care around the patient's home. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Qualitative interview
Time Frame: From 1 to 6 months after the standard monitoring consultation
|
To identify the supportive care needs of patients and parents as well as their expectations with regard to a long-term follow-up
|
From 1 to 6 months after the standard monitoring consultation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quantitative measures to assess adherence to long-term follow-up medical consultation
Time Frame: From 1 to 6 months after the standard monitoring consultation
|
Number of patients summoned/ number of consultations carried out ; reason for refusal of long-term follow-up medical consultation
|
From 1 to 6 months after the standard monitoring consultation
|
|
Clinical Case Report Form to assess the early complications presented by the patients
Time Frame: From 1 to 6 months after the standard monitoring consultation
|
Clinical data : cardiac/renal/bones/digestive/hepatic/endocrine/dermatological/sexual/pulmonary/nutritional damages, pain, physical activity, addictology, tiredness, psychological follow-up
|
From 1 to 6 months after the standard monitoring consultation
|
|
Scores of quality of life
Time Frame: From 1 to 6 months after the standard monitoring consultation
|
For child and adolescent patients (less than 15 years old at inclusion): - Pediatric Quality of Life Inventory Cancer module For patients over 15 years of age at the time of inclusion and parents: - 36-Item Short Form Health Survey |
From 1 to 6 months after the standard monitoring consultation
|
|
Scores of anxiety-depression
Time Frame: From 1 to 6 months after the standard monitoring consultation
|
For child and adolescent patients (less than 15 years old at inclusion):
For patients over 15 years of age at the time of inclusion and parents: - Hospital Anxiety and Depression Scale |
From 1 to 6 months after the standard monitoring consultation
|
|
Quantitative measures to describe and evaluate the offer and use of the network of health professionals who are aware of post-treatment issues
Time Frame: One year after the long-term follow-up consultation
|
number of consultations, speciality and location of the professionals requested following the long-term follow-up consultation, time between referral and first consultation, evaluation of the geographical accessibility of care around the patient's home
|
One year after the long-term follow-up consultation
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- ET20000319
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Solid Tumor or Lymphoma
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownAdvanced Solid Tumor or Hematologic TumorChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingAdvanced Solid Tumor or Hematologic TumorChina
-
Cao Pharmaceuticals Inc.The University of Texas Health Science Center at San AntonioUnknownSolid Tumor | Malignant Lymphoma of Extranodal and/or Solid Organ SiteUnited States
-
Shandong New Time Pharmaceutical Co., LTDUnknownAdvanced Solid Tumor,Recurrent Solid Tumor,Lymphoma,Recurrent Lymphocyte Depleted Classical Hodgkin LymphomaChina
-
Jecho Biopharmaceuticals Co., Ltd.Not yet recruitingSolid Tumor Cancer | Malignancies | Solid Malignant Tumor | NHL (Non-Hodgkin Lymphoma)
-
Eisai Inc.Completed
-
Beijing Mabworks Biotech Co., Ltd.RecruitingAdvanced or Metastatic Solid TumorChina
-
BJ Bioscience, Inc.Active, not recruitingAdvanced Solid Tumor or LymphomaUnited States
-
Astellas Pharma IncCompletedAny Solid Tumor or LymphomaUnited States, Belgium, United Kingdom
-
Tyligand Bioscience (Shanghai) LimitedRecruitingHas a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or LymphomaChina
Clinical Trials on Interview
-
Mayo ClinicNot yet recruitingSpontaneous Coronary Artery DissectionUnited States
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse... and other collaboratorsCompleted
-
Ohio UniversityNew York Blood CenterCompleted
-
University of New MexicoCompletedPregnancy TerminationUnited States
-
Assistance Publique - Hôpitaux de ParisNational Cancer Institute, FranceCompletedCancer | Elderly | Ethnographic Interview | Social Representation of Being Aged | Reasons of Non-participation in Clinical Trials | Qualitative MethodFrance
-
Wayne State UniversityBlue Cross Blue Shield of Michigan FoundationCompleted
-
University of ExeterUniversity of Nottingham; University of Bristol; National Institute for Health...Completed
-
Sakarya UniversityActive, not recruitingNursing Education | Mental Disorder | Stigma of Mental Illness | Implicit Association TestTurkey
-
University of Eastern FinlandCompleted
-
Centro Hospitalar Lisboa NorteUniversity of Lisbon; Faculdade de Psicologia e de Ciências de Educação da...Unknown